Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema

Rationale: Vascular endothelial growth factor receptor (VEGFR) inhibition increases ceramides in lung structural cells of the alveolus, initiating apoptosis and alveolar destruction morphologically resembling emphysema. The effects of increased endogenous ceramides could be offset by sphingosine 1-p...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Diab, Khalil J. (author)
مؤلفون آخرون: Adamowicz, Jeremy J. (author), Kamocki, Krysztof (author), Rush, Natalia I. (author), Garrison, Jana (author), Gu, Yan (author), Schweitzer, Kelly S. (author)
التنسيق: article
منشور في: 2010
الوصول للمادة أونلاين:http://hdl.handle.net/10725/10036
https://doi.org/10.1164/rccm.200906-0826OC
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.atsjournals.org/doi/full/10.1164/rccm.200906-0826OC
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513485778452480
author Diab, Khalil J.
author2 Adamowicz, Jeremy J.
Kamocki, Krysztof
Rush, Natalia I.
Garrison, Jana
Gu, Yan
Schweitzer, Kelly S.
author2_role author
author
author
author
author
author
author_facet Diab, Khalil J.
Adamowicz, Jeremy J.
Kamocki, Krysztof
Rush, Natalia I.
Garrison, Jana
Gu, Yan
Schweitzer, Kelly S.
author_role author
dc.creator.none.fl_str_mv Diab, Khalil J.
Adamowicz, Jeremy J.
Kamocki, Krysztof
Rush, Natalia I.
Garrison, Jana
Gu, Yan
Schweitzer, Kelly S.
dc.date.none.fl_str_mv 2010
2019-02-13T13:18:25Z
2019-02-13T13:18:25Z
2019-02-13
dc.identifier.none.fl_str_mv 1535-4970
http://hdl.handle.net/10725/10036
https://doi.org/10.1164/rccm.200906-0826OC
Diab, K. J., Adamowicz, J. J., Kamocki, K., Rush, N. I., Garrison, J., Gu, Y., ... & Berdyshev, E. V. (2010). Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. American journal of respiratory and critical care medicine, 181(4), 344-352.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.atsjournals.org/doi/full/10.1164/rccm.200906-0826OC
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv American Journal of Respiratory and Critical Care Medicine
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Rationale: Vascular endothelial growth factor receptor (VEGFR) inhibition increases ceramides in lung structural cells of the alveolus, initiating apoptosis and alveolar destruction morphologically resembling emphysema. The effects of increased endogenous ceramides could be offset by sphingosine 1-phosphate (S1P), a prosurvival by-product of ceramide metabolism. Objectives: The aims of our work were to investigate the sphingosine–S1P–S1P receptor axis in the VEGFR inhibition model of emphysema and to determine whether stimulation of S1P signaling is sufficient to functionally antagonize alveolar space enlargement. Methods: Concurrent to VEGFR blockade in mice, S1P signaling augmentation was achieved via treatment with the S1P precursor sphingosine, S1P agonist FTY720, or S1P receptor-1 (S1PR1) agonist SEW2871. Outcomes included sphingosine kinase-1 RNA expression and activity, sphingolipid measurements by combined liquid chromatography–tandem mass spectrometry, immunoblotting for prosurvival signaling pathways, caspase-3 activity and terminal deoxynucleotidyltransferase–mediated dUTP nick end labeling assays, and airspace morphometry. Measurements and Main Results: Consistent with previously reported de novo activation of ceramide synthesis, VEGFR inhibition triggered increases in lung ceramides, dihydroceramides, and dihydrosphingosine, but did not alter sphingosine kinase activity or S1P levels. Administration of sphingosine decreased the ceramide-to-S1P ratio in the lung and inhibited alveolar space enlargement, along with activation of prosurvival signaling pathways and decreased lung parenchyma cell apoptosis. Sphingosine significantly opposed ceramide-induced apoptosis in cultured lung endothelial cells, but not epithelial cells. FTY720 or SEW2871 recapitulated the protective effects of sphingosine on airspace enlargement concomitant with attenuation of VEGFR inhibitor–induced lung apoptosis. Conclusions: Strategies aimed at augmenting the S1P–S1PR1 signaling may be effective in ameliorating the apoptotic mechanisms of emphysema development.
eu_rights_str_mv openAccess
format article
id LAURepo_e37a6d8809f02e60f22d024920feed96
identifier_str_mv 1535-4970
Diab, K. J., Adamowicz, J. J., Kamocki, K., Rush, N. I., Garrison, J., Gu, Y., ... & Berdyshev, E. V. (2010). Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. American journal of respiratory and critical care medicine, 181(4), 344-352.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/10036
publishDate 2010
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysemaDiab, Khalil J.Adamowicz, Jeremy J.Kamocki, KrysztofRush, Natalia I.Garrison, JanaGu, YanSchweitzer, Kelly S.Rationale: Vascular endothelial growth factor receptor (VEGFR) inhibition increases ceramides in lung structural cells of the alveolus, initiating apoptosis and alveolar destruction morphologically resembling emphysema. The effects of increased endogenous ceramides could be offset by sphingosine 1-phosphate (S1P), a prosurvival by-product of ceramide metabolism. Objectives: The aims of our work were to investigate the sphingosine–S1P–S1P receptor axis in the VEGFR inhibition model of emphysema and to determine whether stimulation of S1P signaling is sufficient to functionally antagonize alveolar space enlargement. Methods: Concurrent to VEGFR blockade in mice, S1P signaling augmentation was achieved via treatment with the S1P precursor sphingosine, S1P agonist FTY720, or S1P receptor-1 (S1PR1) agonist SEW2871. Outcomes included sphingosine kinase-1 RNA expression and activity, sphingolipid measurements by combined liquid chromatography–tandem mass spectrometry, immunoblotting for prosurvival signaling pathways, caspase-3 activity and terminal deoxynucleotidyltransferase–mediated dUTP nick end labeling assays, and airspace morphometry. Measurements and Main Results: Consistent with previously reported de novo activation of ceramide synthesis, VEGFR inhibition triggered increases in lung ceramides, dihydroceramides, and dihydrosphingosine, but did not alter sphingosine kinase activity or S1P levels. Administration of sphingosine decreased the ceramide-to-S1P ratio in the lung and inhibited alveolar space enlargement, along with activation of prosurvival signaling pathways and decreased lung parenchyma cell apoptosis. Sphingosine significantly opposed ceramide-induced apoptosis in cultured lung endothelial cells, but not epithelial cells. FTY720 or SEW2871 recapitulated the protective effects of sphingosine on airspace enlargement concomitant with attenuation of VEGFR inhibitor–induced lung apoptosis. Conclusions: Strategies aimed at augmenting the S1P–S1PR1 signaling may be effective in ameliorating the apoptotic mechanisms of emphysema development.PublishedN/A2019-02-13T13:18:25Z2019-02-13T13:18:25Z20102019-02-13Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1535-4970http://hdl.handle.net/10725/10036https://doi.org/10.1164/rccm.200906-0826OCDiab, K. J., Adamowicz, J. J., Kamocki, K., Rush, N. I., Garrison, J., Gu, Y., ... & Berdyshev, E. V. (2010). Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. American journal of respiratory and critical care medicine, 181(4), 344-352.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://www.atsjournals.org/doi/full/10.1164/rccm.200906-0826OCenAmerican Journal of Respiratory and Critical Care Medicineinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/100362021-03-19T10:45:31Z
spellingShingle Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
Diab, Khalil J.
status_str publishedVersion
title Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
title_full Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
title_fullStr Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
title_full_unstemmed Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
title_short Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
title_sort Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema
url http://hdl.handle.net/10725/10036
https://doi.org/10.1164/rccm.200906-0826OC
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.atsjournals.org/doi/full/10.1164/rccm.200906-0826OC